Liquiem Scientific B.V. Expands Global Reach to Support Secure Distribution for International Medical Cannabis Companies
Amsterdam, Netherlands – August 12, 2024 – Liquiem Scientific B.V.,
a leader in the pharmaceutical industry, is proud to announce that it has
entered into strategic agreements with several international medical cannabis
companies to provide secure and safe distribution through its newly established
global hubs. These hubs, located in the European Union (EU), Africa, the United
States (USA), the United Kingdom (UK), and Australia, are designed to ensure
the highest standards of distribution for medical cannabis products worldwide.
As the medical cannabis industry continues to expand rapidly across various
regions, Liquiem Scientific B.V. recognizes the critical importance of secure,
compliant, and efficient distribution channels. The company’s newly established
hubs are strategically positioned to offer robust support to its partners,
ensuring that medical cannabis products reach their intended markets safely and
in full compliance with all relevant regulations.
These new hubs will represent a significant milestone in our commitment to supporting
the global medical cannabis industry. By leveraging our expertise in
pharmaceutical distribution, we aim to provide our partners with the
infrastructure and knowledge they need to navigate the complex regulatory
environments of these key regions. Our goal is to ensure that medical cannabis
products are distributed securely, safely, and efficiently, meeting the highest
standards of quality and compliance.
Liquiem Scientific B.V.’s global hubs will offer a comprehensive range of services,
including secure storage, temperature-controlled logistics, regulatory
compliance support, and efficient distribution networks. These services are
designed to address the unique challenges faced by the medical cannabis
industry, ensuring that products maintain their integrity and meet the
stringent requirements of each regional market.
The strategic locations of these hubs will enable Liquiem Scientific B.V. to
provide seamless distribution support across multiple continents, offering its
partners a reliable and consistent supply chain solution. By establishing a
presence in the EU, Africa, the USA, the UK, and Australia, Liquiem Scientific
B.V. is well-positioned to support the growing demand for medical cannabis
products and facilitate their safe and compliant distribution to patients
around the world.